Medical Imaging Markets: Contrast Agents
Today's capabilities in clinical diagnostic radiology have been made possible by advances not
only in diagnostic systems, but also by the contrast media and radiopharmaceuticals that make it
possible to see, in great detail, the body's internal structures, organs and tissue that would
nototherwise be clearly seen. Although bones are readily apparent on radiographic images, other
organs and tissues are not. These imaging agents may be usedduring a medical imaging
procedure to highlight specific parts of the body andmake them easier to visualize. The
application and versatility of medical imaging modalities are continuing to grow in significance
as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease
diagnosis and the most appropriate treatment are in order. This bodes well for contrast media
Generally, the market for contrast agents and radiopharmaceuticals is expected to sustain decent
growth in the next fewyears, with much of that growth coming from the MRI, ultrasound and
nuclear medicine modalities. While equipment manufacturers may have experienced a slumpin
sales due to the recent recession, there is still a need for these agents,as well as for
radiopharmaceuticals, to help image, track and diagnose disease, especially in the elderly. Even
though hospitals and clinics may have slowed their equipment purchases because of the need to
contain costs, procedures run on installed systems still require the use of contrast agents and
This comprehensive study of the world market for contrast agents builds on the previous
modality-focused reports of Kalorama's medical imaging market reports. Coverage includes:
World and regional revenue forecasts for contrast agents and radiopharmaceuticals by
modality through 2016. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)
Market share of the major contrast agent supplers
Procedure volumes by modality and region
Estimates of the portion of procedures in each modality using contrast enhancement
Contrast-enhancement products in development
The report also discusses technical developments and emerging application trends such as
therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how
contrast agents are helping to expand imaging's role in basic research and drug
discovery/development. Specific advances in contrast agent-enabled diagnostics for
mammography, Alzheimer's, and other indications are also reviewed.
The report concludes with profiles of top suppliers and developers including:
Alseres Pharmaceuticals Inc.
Amag Pharmaceuticals Inc.
Avid Radiopharmaceuticals Inc.
Bayer Schering Pharma
Daiichi Pharmaceutical Co. Ltd.
Dendritic NanoTechnologies Inc.
Hovione FarmaCiencia SA
Imcor Pharmaceutical Co.
Insight Agents GmbH
King Pharmaceuticals Inc.
Palatin Technologies Inc.
Point Biomedical Corp.
Starpharma Holdings Ltd.
VisEn Medical Inc.
Buy your copy of this report @ http://www.reportsnreports.com/reports/260-medical-imaging-
Published: July 2012
No. of Pages: 145
Price : Single User License: US$ 3995 Price : Corporate User License: US$ 7990
Table of contents
HAPTER ONE: Executive Summary
Image Enhancament Overview
X-Ray and CT
World Market Summary
World Market Growth Analysis
CHAPTER TWO: Introduction
Agents for the Early Detection of Disease
Key Clinical Markets
X-Ray and CT
Updated Warning on Microbubbles
Targeted and Untargeted
Sourcing Issues Updated
Ionic and Non-Ionic Contrast
Tracking Contrast Media
Contrast Modality Combinations
CHAPTER THREE: Market Developments
FDA Approves Amyvid
Bayer HealthCare Business Integration
Bayer Receives Gadavist Approval
Agfa's Generic Push
Agfa's Generic Push
Improving Magnetic Resonance Visualization
Tracking Stem Cells
CHAPTER FOUR: Markets
Withstanding the Recession
Combination Imaging and Disease Management
Opportunities from Increasing Specificity
Outlook for Contrast Media
X-Ray and CT
Outlook for Molecular Imaging Agents
CHAPTER FIVE: Corporate Profiles
Alseres Pharmaceuticals, Inc.
Amag Pharmaceuticals Inc
ART Advanced Research Technologies Inc.
Avid Radiopharmaceuticals Inc
Daiichi Pharmaceutucal Co. Ltd
FluoroPharma Medical Inc
Hovione Farmaciencia SA
Lantheus Medical Imaging
Molecular Insight Pharmaceuticals, Inc
Nanoscan Imaginf LLC
Palatin Technologies Inc
Spago Imaging AB
Taejoon Pharmaceutical Co. Ltd
Zim Laboratories India Ltd
Contact: firstname.lastname@example.org for further details.